KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 95 filers reported holding KRONOS BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $52,000 | – | 14,256 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
| Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
| Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
| COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
| Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
| Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
| Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
| Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
| Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |